From a cellular clinical viewpoint, Relafen 750 ( its salt form) presents a compelling case. Its mechanism of function primarily involves inhibiting cyclooxygenase enzymes , specifically COX-1 and COX-2, thereby reducing prostaglandin generation. This contributes to decreased inflammation and fever . The compound's relatively long half-life and spe